Corporate Information And Statement Of Ifrs Compliance [Abstract]
| Concept |
2023-01-01 to 2023-12-31 |
|---|---|
| Corporate information and statement of IFRS compliance [abstract] | |
| Domicile of entity |
Belgium
|
| Legal form of entity |
limited liability company
|
| Address of entity's registered office |
Boulevard Patience
|
| Description of nature of entity's operations and principal activities |
Hyloris is a specialty biopharma company identifying
|
| Name of parent entity |
Hyloris Pharmaceuticals SA
|
| Name of ultimate parent of group |
Hyloris Pharmaceuticals SA
|
| Statement of IFRS compliance [text block] |
The consolidated financial statements of the Group for
|
| Disclosure of reclassifications or changes in presentation [text block] |
31. RESTATEMENT OF 2022 STATEMENTS
|
| Disclosure of material accounting policy information [text block] |
2. SUMMARY OF MATERIAL
|
| Disclosure of objectives, policies and processes for managing capital [text block] |
14
|